Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute… byPallavi MadhirajuOctober 7, 2024